Wai N. Chan

496 total citations
13 papers, 393 citations indexed

About

Wai N. Chan is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Psychiatry and Mental health. According to data from OpenAlex, Wai N. Chan has authored 13 papers receiving a total of 393 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cellular and Molecular Neuroscience, 5 papers in Molecular Biology and 5 papers in Psychiatry and Mental health. Recurrent topics in Wai N. Chan's work include Neuroscience and Neuropharmacology Research (7 papers), Epilepsy research and treatment (4 papers) and Molecular Sensors and Ion Detection (3 papers). Wai N. Chan is often cited by papers focused on Neuroscience and Neuropharmacology Research (7 papers), Epilepsy research and treatment (4 papers) and Molecular Sensors and Ion Detection (3 papers). Wai N. Chan collaborates with scholars based in United Kingdom and United States. Wai N. Chan's co-authors include Neil Upton, Jeffrey C. Jerman, Michael S. Hadley, Tania O. Stean, Mervyn Thompson, Hugh J. Herdon, John Evans, Darren Smart, Stephen Brough and Amanda Johns and has published in prestigious journals such as Journal of Medicinal Chemistry, British Journal of Pharmacology and Psychopharmacology.

In The Last Decade

Wai N. Chan

13 papers receiving 351 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Wai N. Chan United Kingdom	9	192	180	146	98	96	13	393
Martyn C. Coldwell United Kingdom	14	131 0.7×	109 0.6×	91 0.6×	347 3.5×	308 3.2×	24	632
Petra Hoever Switzerland	11	700 3.6×	620 3.4×	610 4.2×	44 0.4×	63 0.7×	22	822
Peter D. Alfinito United States	14	36 0.2×	68 0.4×	24 0.2×	170 1.7×	148 1.5×	20	456
Dennis Mircsof Switzerland	5	91 0.5×	105 0.6×	24 0.2×	163 1.7×	96 1.0×	6	346
Yasir El‐Sherif United States	8	96 0.5×	157 0.9×	13 0.1×	65 0.7×	132 1.4×	11	362
Nigel Deeks United Kingdom	8	96 0.5×	58 0.3×	13 0.1×	301 3.1×	350 3.6×	11	608
John D. Schreier United States	9	128 0.7×	108 0.6×	107 0.7×	131 1.3×	27 0.3×	10	377
Patrizia Aracri Italy	12	113 0.6×	45 0.3×	24 0.2×	247 2.5×	249 2.6×	13	405
Paul S. Blum United States	13	130 0.7×	65 0.4×	18 0.1×	99 1.0×	140 1.5×	17	415
Craig A. Stump United States	10	28 0.1×	38 0.2×	22 0.2×	83 0.8×	78 0.8×	11	264

Countries citing papers authored by Wai N. Chan

Since Specialization

Citations

This map shows the geographic impact of Wai N. Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wai N. Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wai N. Chan more than expected).

Fields of papers citing papers by Wai N. Chan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wai N. Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wai N. Chan. The network helps show where Wai N. Chan may publish in the future.

Co-authorship network of co-authors of Wai N. Chan

This figure shows the co-authorship network connecting the top 25 collaborators of Wai N. Chan. A scholar is included among the top collaborators of Wai N. Chan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wai N. Chan. Wai N. Chan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Duxon, Mark, Kathryn R. Starr, Declan N.C. Jones, et al.. (2001). Evidence that orexin-A-evoked grooming in the rat is mediated by orexin-1 (OX 1 ) receptors, with downstream 5-HT 2C receptor involvement. Psychopharmacology. 153(2). 203–209. 79 indexed citations

Porter, Roderick A., Wai N. Chan, Steven Coulton, et al.. (2001). 1,3-Biarylureas as selective non-peptide antagonists of the orexin-1 receptor. Bioorganic & Medicinal Chemistry Letters. 11(14). 1907–1910. 119 indexed citations

Chan, Wai N., Michael S. Hadley, John D. Harling, et al.. (2000). Evaluation of a Series of Anticonvulsant 1,2,3,4-Tetrahydroisoquinolinyl-benzamides. Bioorganic & Medicinal Chemistry. 8(8). 2085–2094. 8 indexed citations

Herdon, Hugh J., et al.. (2000). Use of the radioligand [125I]-SB-217644 in the characterisation and solubilisation of the novel binding site for the anticonvulsant SB-204269 in rat brain membranes and cell lines. Neuropharmacology. 39(12). 2457–2463. 3 indexed citations

Chan, Wai N., John Evans, Michael S. Hadley, et al.. (1999). Identification of (−)-cis-6-acetyl-4S-(3-chloro-4-fluoro-benzoylamino)-3,4-dihydro-2,2-dimethyl-2H-benzo[b]pyran-3S-ol as a potential antimigraine agent. Bioorganic & Medicinal Chemistry Letters. 9(2). 285–290. 46 indexed citations

Chan, Wai N., Michael S. Hadley, John D. Harling, et al.. (1998). Identification of a series of 1,2,3,4-tetrahydroisoquinolinyl- benzamides with potential anticonvulsant activity. Bioorganic & Medicinal Chemistry Letters. 8(20). 2903–2906. 12 indexed citations

Herdon, Hugh J., Jeffrey C. Jerman, Tania O. Stean, et al.. (1997). Characterization of the binding of [³H]‐SB‐204269, a radiolabelled form of the new anticonvulsant SB‐204269, to a novel binding site in rat brain membranes. British Journal of Pharmacology. 121(8). 1687–1691. 30 indexed citations

Chan, Wai N., John Evans, Michael S. Hadley, et al.. (1997). Conformational preference of the 6-acetyl group in novel anticonvulsant trans 4S-benzamido-benzo[b]pyran-3R-ols. Bioorganic & Medicinal Chemistry Letters. 7(12). 1573–1576. 2 indexed citations

Upton, Neil, T.P. Blackburn, Colin A. Campbell, et al.. (1997). Profile of SB‐204269, a mechanistically novel anticonvulsant drug, in rat models of focal and generalized epileptic seizures. British Journal of Pharmacology. 121(8). 1679–1686. 39 indexed citations

10.

Herdon, Hugh J., Jeff Jerman, Tania O. Stean, et al.. (1996). The novel anticonvulsant SB 204269 binds to a stereospecific site in the mouse brain. European Journal of Pharmacology. 314(3). R7–R8. 10 indexed citations

11.

Chan, Wai N., John Evans, Michael S. Hadley, et al.. (1996). Synthesis of Novel trans-4-(Substituted-benzamido)-3,4-dihydro-2H-benzo[b]pyran-3-ol Derivatives as Potential Anticonvulsant Agents with a Distinctive Binding Profile. Journal of Medicinal Chemistry. 39(23). 4537–4539. 22 indexed citations

12.

Blackburn, Thomas P., Robin E. Buckingham, Wai N. Chan, et al.. (1995). Stereochemical differentiation of anticonvulsant and antihypertensive effects in 4-(fluorobenzoylamino)-benzopyrans. Bioorganic & Medicinal Chemistry Letters. 5(11). 1163–1166. 17 indexed citations

13.

Brown, Thomas H., Colin A. Campbell, Wai N. Chan, et al.. (1995). Stereochemical preferences and requirement for the 3-hydroxyl group in novel anticonvulsant 4-fluorobenzoylamino benzopyrans. Bioorganic & Medicinal Chemistry Letters. 5(21). 2563–2566. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact